Generic drug manufacturers see new opportunities ahead

Generic drug manufacturers see new opportunities ahead

Turmoil in generics brings opportunity for fine chemicals firms Declining prices and a saturated market could spell doom-and-gloom for the generic pharmaceutical industry, but some in the business are turning lemons into lemonade, seeing opportunities instead. According to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, these […]

Clock ticking on a bipartisan scramble to curb drug costs

Clock ticking on a bipartisan scramble to curb drug costs

With only two weeks left in the legislative session, a Democratic lawmaker and the state comptroller are feverishly working to bring to the House floor proposed legislation that is considered Connecticut’s most comprehensive effort so far to control high prescription drug costs. The bill aims to shine light on the murky supply chain and money […]

Drug Pricing Proposal Should Revamp Medicare, GOP Experts Say

Drug Pricing Proposal Should Revamp Medicare, GOP Experts Say

An upcoming Trump administration proposal on lowering drug costs should ask Congress to allow private insurance companies to negotiate prices for drugs administered in a doctor’s office or hospital, two Republican policy experts said. The administration’s proposal is a request for comment on strategies to lower drug prices and out-of-pocket costs. It was originally expected […]

India's Doctors 'Deeply Pained' by Modi's 'Unjust' Remarks in London

India's Doctors 'Deeply Pained' by Modi's 'Unjust' Remarks in London

Mumbai: Doctors across India have expressed disappointment over Prime Minister Narendra Modi’s statements made during his visit to London last week. Calling the remarks “unjust” and “uncalled for”, doctors’ associations from across the country have decided to mark their unhappiness through letters and protests. During his three-day trip to London last week, among other things, […]

Hurvitz Shares Insight on Breaking the Barrier With Biosimilars

Hurvitz Shares Insight on Breaking the Barrier With Biosimilars

Sara A. Hurvitz, MD Although filgrastim-sndz (Zarxio), a biosimilar for the G-CSF analog filgrastim (Neupogen), is the only biosimilar commonly used in oncology practice, several studies have confirmed the benefit of biosimilars for trastuzumab (Herceptin) that could potentially lead to their routine clinical use once the anti-HER2 agent comes off patent, explains Sara A. Hurvitz, […]

Generic-Drug Companies to Face First Charges in US Probe

Generic-Drug Companies to Face First Charges in US Probe

U.S. prosecutors are nearing their first charges against companies in an almost four-year-old criminal investigation into alleged price-fixing by generic-drug makers, according to people familiar with the matter. At least two companies are on track to be indicted in the coming months, in addition to several executives, said two people, who spoke on condition of […]

Maryland's Drug Price-Gouging Law Struck Down As Unconstitutional

Maryland's Drug Price-Gouging Law Struck Down As Unconstitutional

On Friday, April 13, 2018, in an opinion that may have far-reaching effects, the United States Court of Appeals for the Fourth Circuit found Maryland’s new drug price-gouging prohibition law unconstitutional under the dormant Commerce Clause of the United States Constitution, which generally constrains states’ power to enact legislation that interferes with or burdens interstate […]

Publix deal charges $2.50 a month for generic drugs

Publix deal charges $2.50 a month for generic drugs

Publix pharmacies now charge a cut-rate price of $7.50 for a 90-day supply of certain common generic medications. That’s cheaper than Walmart and equivalent to paying $2.50 a month. The deal includes the generic versions of the cholesterol drug Zocor (simvastatin), the Alzheimer’s Disease medication Aricept (donepezil), the anti-inflammatory medication Mobic (meloxicam), the prostate drug […]